0.000USD0.000Pre-market 08/03, 09:30 (ET)
433.28MMarket Cap
LossP/E TTM
Key Figures
2.430Open
2.460High
8.33MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.16%Turnover Ratio
2.890Prev. Close
2.060Low
13.48MTurnover
LossP/E Static
6.38P/B
0.00%Div Yield TTM
-4.45%ROA
3.15052wk High
2.70Volume Ratio
-20.92MNet Profit
200.32MShares
-0.0492EPS TTM
1.73Beta
-15.52%ROE
1.15052wk Low
13.84%Amplitude
75.71%Gross Margin
433.28MMarket Cap
-3.00Reward/Risk
3.96%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Cerus Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Cerus Corp Highlights
StrengthsRisks
Cerus Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cerus Corp Info
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.
Ticker SymbolCERS
CompanyCerus Corp
CEOGreenman (William M)
Websitehttps://www.cerus.com/
Shareholders
FAQs
What is the current price of Cerus Corp (CERS)?
The current price of Cerus Corp (CERS) is 2.15.
What is the symbol of Cerus Corp?
The ticker symbol of Cerus Corp is CERS.
What is the 52-week high of Cerus Corp?
The 52-week high of Cerus Corp is 3.15.
What is the 52-week low of Cerus Corp?
The 52-week low of Cerus Corp is 1.15.
What is the market capitalization of Cerus Corp?
The market capitalization of Cerus Corp is 433.28M.
Is Cerus Corp (CERS) currently rated as Buy, Hold, or Sell?
According to analysts, Cerus Corp (CERS) has an overall rating of Buy, with a price target of 4.67.
What is the Earnings Per Share (EPS TTM) of Cerus Corp (CERS)?
The Earnings Per Share (EPS TTM) of Cerus Corp (CERS) is -0.08.
